GB1522600A – Proteins
– Google Patents
GB1522600A – Proteins
– Google Patents
Proteins
Info
Publication number
GB1522600A
GB1522600A
GB5188574A
GB5188574A
GB1522600A
GB 1522600 A
GB1522600 A
GB 1522600A
GB 5188574 A
GB5188574 A
GB 5188574A
GB 5188574 A
GB5188574 A
GB 5188574A
GB 1522600 A
GB1522600 A
GB 1522600A
Authority
GB
United Kingdom
Prior art keywords
water
soluble
plant material
separation
solution
Prior art date
1975-12-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5188574A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1975-12-01
Filing date
1975-12-01
Publication date
1978-08-23
1975-12-01
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH
filed
Critical
CH Boehringer Sohn AG and Co KG
1975-12-01
Priority to GB5188574A
priority
Critical
patent/GB1522600A/en
1978-08-23
Publication of GB1522600A
publication
Critical
patent/GB1522600A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K36/18—Magnoliophyta (angiosperms)
A61K36/185—Magnoliopsida (dicotyledons)
A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K36/18—Magnoliophyta (angiosperms)
A61K36/185—Magnoliopsida (dicotyledons)
A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0012—Galenical forms characterised by the site of application
A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/20—Pills, tablets, discs, rods
A61K9/2004—Excipients; Inactive ingredients
A61K9/2022—Organic macromolecular compounds
A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
1522600 Plant protein purification BOEHRINGER INGELHEIM GmbH 1 Dec 1975 [29 Nov 1974] 51885/74 Heading C3H Water-soluble by-protein or mixture of byproteins in substantially pure form obtainable from the plant material of Canavalia ensiformis, Abeus praecatorius or Ricinus communis containing water-soluble agglutinins and/or toxins by separation of the latter component(s) from the water-soluble protein component(s) of the plant material are claimed per se. The plant material (preferably in the form of seeds) may be crushed, degreased and subjected to a first separation by means of extraction from NaCl solution and dialysing the water-insoluble toxic globulins. The remaining clean solution is further purified by salting out several times with a saturated (NH4)2SO4 solution. Final separation may be effected by electrophoresis, membrane diafiltration or chromatography.
GB5188574A
1975-12-01
1975-12-01
Proteins
Expired
GB1522600A
(en)
Priority Applications (1)
Application Number
Priority Date
Filing Date
Title
GB5188574A
GB1522600A
(en)
1975-12-01
1975-12-01
Proteins
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
GB5188574A
GB1522600A
(en)
1975-12-01
1975-12-01
Proteins
Publications (1)
Publication Number
Publication Date
GB1522600A
true
GB1522600A
(en)
1978-08-23
Family
ID=10461783
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
GB5188574A
Expired
GB1522600A
(en)
1975-12-01
1975-12-01
Proteins
Country Status (1)
Country
Link
GB
(1)
GB1522600A
(en)
Cited By (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4414201A
(en)
1979-11-09
1983-11-08
Eisai Co., Ltd.
Immunopotentiator containing abrin
US4459287A
(en)
*
1979-11-09
1984-07-10
Eisai Co., Ltd.
Immunopotentiator containing recin
EP0196762A1
(en)
*
1985-03-29
1986-10-08
Cetus Corporation
Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
US5840522A
(en)
*
1984-09-20
1998-11-24
Chiron Corporation
Recombinant lectins
US6084073A
(en)
*
1985-03-25
2000-07-04
Chiron Corporation
Recombinant ricin toxin
1975
1975-12-01
GB
GB5188574A
patent/GB1522600A/en
not_active
Expired
Cited By (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4414201A
(en)
1979-11-09
1983-11-08
Eisai Co., Ltd.
Immunopotentiator containing abrin
US4459287A
(en)
*
1979-11-09
1984-07-10
Eisai Co., Ltd.
Immunopotentiator containing recin
US5840522A
(en)
*
1984-09-20
1998-11-24
Chiron Corporation
Recombinant lectins
US6084073A
(en)
*
1985-03-25
2000-07-04
Chiron Corporation
Recombinant ricin toxin
EP0196762A1
(en)
*
1985-03-29
1986-10-08
Cetus Corporation
Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
Similar Documents
Publication
Publication Date
Title
Maček et al.
1988
Isolation and characterization of three lethal and hemolytic toxins from the sea anemone Actinia equina L.
Ferlan et al.
1974
Equinatoxin, a lethal protein from Actinia equina—I Purification and characterization
Palau et al.
1969
Histones from sperm of the sea urchin Arbacia lixula
Csordas et al.
1969
Primary structure of two oligopeptides of the toxin of Bombina variegata L.
DK485287A
(en)
1988-03-18
MEGAKARYOCYT STIMULATING FACTOR AND PROCEDURE FOR ISOLATING SUCH A FACTOR
DE3684078D1
(en)
1992-04-09
CLEANING AND ACTIVATION OF PROTEINS FROM INSOLUBLE INCLUDING BODIES.
ES8306572A1
(en)
1983-06-01
Fractionation and isolation of 7S and 11S protein from isoelectrically precipitated vegetable protein mixtures.
EP0404202A3
(en)
1991-06-12
Agent for separating proteins from blood plasma
Lowy et al.
1959
On the erythropoietic principle in the blood of rabbits made severely anemic with phenylhydrazine
GB1496726A
(en)
1977-12-30
Fractionation of proteins by electrical means
Cohen et al.
1964
Preparation of human chorionic “growth hormone-prolactin.”
Seyer et al.
1969
The content and nature of the carbohydrate components of the organic matrix of embryonic bovine enamel
GB1522600A
(en)
1978-08-23
Proteins
DE3230151A1
(en)
1984-02-16
NEW POLYPEPTIDE WITH EFFECT ON THE IMMUNE SYSTEM, METHOD FOR ITS INSULATION AND CLEANING, ITS USE, ITS CONTAINER, AND ITS DIFFERENT PRODUCTS, THEIR USE AND ITEMS
Ito et al.
1952
Studies on the Salivary Gland Hormones. XIV Isolation of Crystalline Parotin by Fractional Precipitation with Ammonium Sulfate
Moroz-Perlmutter et al.
1965
Biochemical and antigenic properties of a purified neurotoxin of Vipera palestinae venom
Daly et al.
1955
SYNTHESIS OF PROTEIN IN THE PANCREAS: III. UPTAKE OF GLYCINE-N15BY THE TRYPSINOGEN AND CHYMOTRYPSINOGEN OF MOUSE PANCREAS
GB1018528A
(en)
1966-01-26
New physiologically active protein fractions from mistletoe and process for their preparation
ES8800275A1
(en)
1987-11-01
POLYDISPERSED NATIVE PSEUDOMONAS-FLAGELLA (H)-ANTIGENS (FAg) AND METHODS FOR THEIR PREPARATION.
US3475402A
(en)
1969-10-28
Process of extracting proteins from mistle press juice by carrier-free electrophoresis
DE3166700D1
(en)
1984-11-22
A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
Bernlohr et al.
1958
Formation of Activated Amino-Acids by Intact Cells of Azotobacter vinelandii
Yamazaki et al.
1969
Isolation and purification of colostrokinin from bovine colostrum
Rangneker et al.
1958
A NOTE ON THE EFFECT OF GOLD AND VITAMIN C ON THE BLOOD LEVELS OF PHENYLALANINE AND TYROSINE IN RATS
Tewksbury et al.
1974
Preparation of human angiotensinogen for plasma renin concentration assay
Legal Events
Date
Code
Title
Description
1979-05-02
CSNS
Application of which complete specification have been accepted and published, but patent is not sealed
